IDXX
Price
$412.26
Change
+$3.23 (+0.79%)
Updated
Dec 20, 04:59 PM (EDT)
50 days until earnings call
NSTM
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
Dec 20 closing price
Ad is loading...

IDXX vs NSTM

Header iconIDXX vs NSTM Comparison
Open Charts IDXX vs NSTMBanner chart's image
IDEXX Laboratories
Price$412.26
Change+$3.23 (+0.79%)
Volume$7.84K
CapitalizationN/A
NovelStem International
Price$0.01
Change-$0.00 (-0.00%)
Volume$10K
CapitalizationN/A
IDXX vs NSTM Comparison Chart
Loading...
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDXX vs. NSTM commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDXX is a Hold and NSTM is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (IDXX: $412.26 vs. NSTM: $0.01)
Brand notoriety: IDXX and NSTM are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IDXX: 156% vs. NSTM: 46%
Market capitalization -- IDXX: $44.84B vs. NSTM: $10.63M
IDXX [@Medical Specialties] is valued at $44.84B. NSTM’s [@Medical Specialties] market capitalization is $10.63M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDXX’s FA Score shows that 1 FA rating(s) are green whileNSTM’s FA Score has 0 green FA rating(s).

  • IDXX’s FA Score: 1 green, 4 red.
  • NSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, IDXX is a better buy in the long-term than NSTM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDXX’s TA Score shows that 3 TA indicator(s) are bullish while NSTM’s TA Score has 2 bullish TA indicator(s).

  • IDXX’s TA Score: 3 bullish, 5 bearish.
  • NSTM’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, both IDXX and NSTM are a bad buy in the short-term.

Price Growth

IDXX (@Medical Specialties) experienced а -4.59% price change this week, while NSTM (@Medical Specialties) price change was +0.68% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

IDXX is expected to report earnings on Feb 10, 2025.

NSTM is expected to report earnings on Nov 18, 2024.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDXX($44.8B) has a higher market cap than NSTM($10.6M). IDXX YTD gains are higher at: -25.726 vs. NSTM (-82.393). IDXX has higher annual earnings (EBITDA): 1.22B vs. NSTM (-758.27K). IDXX has more cash in the bank: 454M vs. NSTM (40.6K). NSTM has less debt than IDXX: NSTM (358K) vs IDXX (1.07B). IDXX has higher revenues than NSTM: IDXX (3.66B) vs NSTM (12K).
IDXXNSTMIDXX / NSTM
Capitalization44.8B10.6M422,642%
EBITDA1.22B-758.27K-160,629%
Gain YTD-25.726-82.39331%
P/E Ratio52.87N/A-
Revenue3.66B12K30,508,333%
Total Cash454M40.6K1,118,227%
Total Debt1.07B358K298,045%
FUNDAMENTALS RATINGS
IDXX vs NSTM: Fundamental Ratings
IDXX
NSTM
OUTLOOK RATING
1..100
7650
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
49
Fair valued
PROFIT vs RISK RATING
1..100
58100
SMR RATING
1..100
1797
PRICE GROWTH RATING
1..100
6395
P/E GROWTH RATING
1..100
87100
SEASONALITY SCORE
1..100
4526

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NSTM's Valuation (49) in the null industry is somewhat better than the same rating for IDXX (84) in the Medical Specialties industry. This means that NSTM’s stock grew somewhat faster than IDXX’s over the last 12 months.

IDXX's Profit vs Risk Rating (58) in the Medical Specialties industry is somewhat better than the same rating for NSTM (100) in the null industry. This means that IDXX’s stock grew somewhat faster than NSTM’s over the last 12 months.

IDXX's SMR Rating (17) in the Medical Specialties industry is significantly better than the same rating for NSTM (97) in the null industry. This means that IDXX’s stock grew significantly faster than NSTM’s over the last 12 months.

IDXX's Price Growth Rating (63) in the Medical Specialties industry is in the same range as NSTM (95) in the null industry. This means that IDXX’s stock grew similarly to NSTM’s over the last 12 months.

IDXX's P/E Growth Rating (87) in the Medical Specialties industry is in the same range as NSTM (100) in the null industry. This means that IDXX’s stock grew similarly to NSTM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDXXNSTM
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
76%
MACD
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
51%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
50%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 14 days ago
70%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
71%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
78%
View a ticker or compare two or three
Ad is loading...
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GSM3.870.10
+2.73%
Ferroglobe PLC
BGNE176.501.78
+1.02%
BeiGene Ltd
SSTI12.330.04
+0.33%
SoundThinking
EDUC1.58-0.01
-0.63%
Educational Development Corp
NPO173.22-2.18
-1.24%
Enpro

IDXX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDXX has been loosely correlated with MYGN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IDXX jumps, then MYGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDXX
1D Price
Change %
IDXX100%
+0.79%
MYGN - IDXX
48%
Loosely correlated
+1.44%
TFX - IDXX
46%
Loosely correlated
+1.93%
TMO - IDXX
45%
Loosely correlated
+1.42%
SNN - IDXX
43%
Loosely correlated
-0.52%
IQV - IDXX
43%
Loosely correlated
+3.00%
More

NSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, NSTM has been loosely correlated with SNN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NSTM jumps, then SNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NSTM
1D Price
Change %
NSTM100%
-3.40%
SNN - NSTM
43%
Loosely correlated
-0.52%
TFX - NSTM
39%
Loosely correlated
+1.93%
IDXX - NSTM
27%
Poorly correlated
+0.79%
TRXO - NSTM
27%
Poorly correlated
N/A
XVIPF - NSTM
22%
Poorly correlated
N/A
More